HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Chong Shen Selected Research
Chong Shen Research Topics
Disease
24
Hypertension (High Blood Pressure)
01/2022 - 08/2007
14
Neoplasms (Cancer)
08/2022 - 02/2012
11
Stroke (Strokes)
08/2022 - 01/2013
11
Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 05/2012
11
Type 2 Diabetes Mellitus (MODY)
01/2019 - 01/2012
8
Ischemic Stroke
01/2022 - 03/2013
8
Genetic Predisposition to Disease (Genetic Predisposition)
01/2021 - 01/2015
5
Colitis
12/2008 - 07/2004
5
Crohn Disease (Crohn's Disease)
12/2008 - 10/2002
4
Atherosclerosis
08/2022 - 01/2020
4
Obesity
10/2021 - 02/2012
4
Schizophrenia (Dementia Praecox)
01/2021 - 05/2015
4
Coronary Disease (Coronary Heart Disease)
01/2021 - 03/2012
4
Hemorrhagic Stroke
12/2019 - 08/2017
4
Essential Hypertension
11/2019 - 11/2009
4
Secondary Hyperparathyroidism
12/2018 - 01/2016
3
Overweight
01/2022 - 10/2013
3
Osteoarthritis
11/2021 - 01/2018
3
Urinary Bladder Neoplasms (Bladder Cancer)
07/2021 - 01/2020
3
Dyslipidemias (Dyslipidemia)
01/2021 - 05/2018
3
Drug-Related Side Effects and Adverse Reactions
01/2021 - 01/2012
3
Chronic Renal Insufficiency
12/2018 - 01/2016
3
Inflammation (Inflammations)
01/2018 - 03/2007
3
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 02/2012
3
Rheumatoid Arthritis
08/2006 - 06/2005
2
Lung Neoplasms (Lung Cancer)
08/2022 - 12/2020
2
Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2021
2
Vascular Remodeling
01/2020 - 01/2014
2
Carcinogenesis
01/2020 - 10/2014
2
Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 01/2013
2
Methylmalonic acidemia
10/2016 - 03/2012
2
Fatty Liver
06/2016 - 07/2009
2
Insulin Resistance
01/2016 - 05/2015
2
Abdominal Obesity
01/2016 - 02/2012
2
Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
01/2016 - 01/2016
2
Myocardial Infarction
03/2013 - 01/2013
2
Edema (Dropsy)
08/2006 - 07/2004
1
Prostatic Neoplasms (Prostate Cancer)
08/2022
1
Prehypertension
01/2022
1
Coinfection
07/2021
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2021
Drug/Important Bio-Agent (IBA)
9
Lipids
IBA
01/2022 - 02/2012
8
Particulate Matter
IBA
01/2022 - 01/2019
7
ORALIT (ORS)
IBA
01/2022 - 01/2012
7
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2015
7
Proteins (Proteins, Gene)
FDA Link
01/2021 - 04/2009
7
Messenger RNA (mRNA)
IBA
01/2021 - 03/2007
6
HDL Cholesterol
IBA
12/2019 - 02/2012
6
Glucose (Dextrose)
FDA Link
Generic
06/2019 - 02/2012
5
Triglycerides (Triacylglycerol)
IBA
01/2022 - 02/2012
5
C-Reactive Protein
IBA
11/2019 - 05/2012
5
Transforming Growth Factor-beta Type II Receptor
IBA
01/2019 - 09/2012
4
Cholesterol
IBA
01/2022 - 06/2016
4
Calcitriol Receptors (Calcitriol Receptor)
IBA
08/2018 - 09/2014
3
MicroRNAs (MicroRNA)
IBA
08/2022 - 01/2019
3
oxidized low density lipoprotein
IBA
01/2022 - 08/2018
3
Circular RNA
IBA
07/2021 - 01/2019
3
Enzymes
IBA
02/2021 - 08/2020
3
Acids
IBA
08/2020 - 07/2004
3
LDL Cholesterol
IBA
12/2019 - 10/2015
3
Insulin (Novolin)
FDA Link
10/2018 - 01/2013
3
Cytokines
IBA
01/2015 - 10/2002
3
Pharmaceutical Preparations
IBA
11/2014 - 07/2009
3
Monoclonal Antibodies
IBA
03/2007 - 06/2005
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
08/2006 - 06/2005
2
A 17 (A-17)
IBA
01/2022 - 08/2021
2
Reactive Oxygen Species (Oxygen Radicals)
IBA
11/2021 - 05/2012
2
Tea
IBA
08/2021 - 12/2020
2
Interleukin-6 (Interleukin 6)
IBA
01/2021 - 12/2008
2
Antipsychotic Agents (Antipsychotics)
IBA
01/2021 - 01/2018
2
Indicators and Reagents (Reagents)
IBA
01/2021 - 07/2010
2
Insulin-Like Peptides
IBA
01/2020 - 09/2017
2
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2019 - 02/2012
2
Antihypertensive Agents (Antihypertensives)
IBA
01/2019 - 01/2014
2
Hormones (Hormone)
IBA
12/2018 - 10/2014
2
Bilirubin
IBA
09/2018 - 11/2017
2
Ethanol (Ethyl Alcohol)
IBA
08/2018 - 08/2006
2
Apolipoproteins E (ApoE)
IBA
01/2018 - 02/2016
2
Collagen Type I (Type I Collagen)
IBA
11/2016 - 03/2005
2
mevalonate kinase
IBA
10/2016 - 03/2012
2
Vitamin B 12 (Cyanocobalamin)
FDA Link
Generic
10/2016 - 03/2012
2
Blood Glucose (Blood Sugar)
IBA
06/2016 - 02/2012
2
Uric Acid (Urate)
IBA
06/2016 - 01/2013
2
Leptin
IBA
01/2016 - 01/2016
2
Fibrillin-1
IBA
01/2014 - 06/2011
2
Antibodies
IBA
11/2012 - 12/2008
2
Oxazolone
IBA
03/2007 - 07/2004
2
Haptens
IBA
03/2007 - 07/2004
2
Interferon-gamma (Interferon, gamma)
IBA
03/2007 - 10/2002
2
Pteridines
IBA
01/2007 - 08/2006
2
Infliximab (Remicade)
FDA Link
01/2006 - 06/2005
1
Carcinogens
IBA
08/2022
1
chromium hexavalent ion
IBA
08/2022
1
cyclo(Arg-Pro) (CI 4)
IBA
01/2022
1
Solutions
IBA
07/2021
1
Immunosorbents
IBA
02/2021
Therapy/Procedure
7
Therapeutics
08/2022 - 06/2005
4
Parathyroidectomy
12/2018 - 01/2016
2
Rectal Administration
01/2007 - 08/2006
1
Secondary Prevention
03/2021